Bronchodilator, vasodilator and spasmolytic activities of methanolic extract of Myrtus communis L.

Journal of Physiology and Pharmacology

Volumn 64, Issue 4, 2013, Pages 479-484

  Janbaz, K H ^a   Nisa, M ^a   Saqib, F ^a   Imran, I ^a   Zia Ul Haq, M ^b   De Feo, Vincenzo ^c  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b The Patent Office   (Pakistan)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Bronchodilatory effect; Myrtus communis; Spasmolytic effect; Vasorelaxant effect

Indexed keywords

CALCIUM; CARBACHOL; METHANOL; MYRTUS COMMUNIS EXTRACT; POTASSIUM ION; VERAPAMIL;

ANIMAL TISSUE; AORTA; ARTICLE; BRONCHODILATING ACTIVITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; ISOLATED ORGAN; JEJUNUM; MALE; NONHUMAN; RABBIT; RESPIRATORY TRACT DISEASE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SPASMOLYTIC ACTIVITY; TRACHEA; VASCULAR DISEASE; VASODILATING ACTIVITY;

ANIMALS; AORTA, THORACIC; BRONCHODILATOR AGENTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; JEJUNUM; MUSCLE CONTRACTION; MYRTUS; PARASYMPATHOLYTICS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; RABBITS; TRACHEA; VASODILATOR AGENTS;

EID: 84884962975     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Sumbull S, Ahmad MA, Asif M, Akhtar M. Myrtus communis Linn. A review. Indian J Nat Prod Resour 2011; 2: 395-402.
2. Akin M, Aktumsek A, Nostro A. Antibacterial activity and composition of the essential oils of Eucalyptus camaldulensis Dehn. and Myrtus communis L. growing in Northern Cyprus. Afr J Biotechnol 2010; 9: 531-535.
3. Rosa A, Melis MP, Deiana M, et al. Protective effect of the oligomeric acylphloroglucinols from Myrtus communis on cholesterol and human low density lipoprotein oxidation. Chem Phys Lipids 2008; 155: 16-23.
4. Gerbeth K, Meins J, Werz O, Schubert-Zsilavecz M, Abdel-Tawab M. Determination of myrtucommulone from Myrtus communis in human and rat plasma by liquid chromatography/tandem mass spectrometry. Planta Med 2011; 77: 450-454.
5. Mimica-Dukic N, Bugarin D, Grbovic S, et al. Essential oil of Myrtus communis L. as a potential antioxidant and antimutagenic agents. Molecules 2010; 15: 2759-2770.
6. Babaee N, Mansourian A, Momen-Heravi F, Moghadamnia A, Momen-Beitollahi J. The efficacy of a paste containing Myrtus communis (Myrtle) in the management of recurrent aphthous stomatitis: a randomized controlled trial. Clin Oral Investig 2010; 14: 65-70.
7. Hakeem MA. Bustanul Mufradat. Lucknow, Idara Tarraqui Urdu Publications, 1895.
8. Trease W, Evans D. Pharmacognosy. Toronto, W.B. Saunders Comp Ltd., 2006.
9. Ali M, Ansari SH. Herbal drugs used as hair tonic. In: National Seminar on the Use of Traditional Medicinal Plants in Skincare, CIMAP, Lucknow, November 25-26, 1994, pp. 20.
10. Nadkarni KM. The Indian Materia Medica, Vol. 1, Mumbai, India, Popular Parkashan Private Limited, 1982; pp. 838-839.
11. Ozkol H, Tuluce Y, Dilsiz N, Koyuncu I. Therapeutic potential of some plant extracts used in Turkish traditional medicine on streptozocin-induced type 1 diabetes mellitus in rats. J Membr Biol 2013; 246: 47-55.
12. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants, Publications and Information Directorate, Delhi, CSIR, 1956, pp. 173.
13. Flaminia G, Cionia P, Morellia I, Maccioni S, Baldini R. Phytochemical typologies in some populations of Myrtus communis L. on Caprione Promontory (East Liguria, Italy). Food Chem 2004; 85: 599-604.
14. Dogan A. Investigations of Myrtus communis L. plant's volatile oil yield, their physical-chemical properties and their compositions. Ankara University, Agricultural Faculty Press, 1978.
15. Ozek T, Demirci B, Baser KH. Chemical composition of Turkish myrtle oil. J Essent Oil Res 2000; 12: 541-544.
16. Satrani B, Farah A, Talbi M. Fractional distillation effect on the chemical composition and antimicrobial activity of Moroccan Myrtle. Acta Bot Gallica 2006; 153: 235-242.
17. Martin T, Villaescusa L, De Sotto M, Lucia A, Diaz AM. Determination of anthocyanin pigments in Myrtus communis berries. Fitoterapia 1990; 61: 85.
18. Cakir A. Essential oil and fatty acid composition of the fruits of Hippophae rhamnoides and Myrtus communis from Turkey. J Biochem Sys Ec 2004; 32: 809-816.
19. Hayder N, Abdelwahed A, Kilani S, et al. Anti-genotoxic and free-radical scavenging activities of extracts from Myrtus communis. J Mutat Res 2004; 564: 89-95.
20. Joseph MI, Pichon PN, Raynaud J. Flavonoid heterosides of the leaves of Myrtus communis L. (Myrtaceae). Pharmazie 1987; 42: 142.
21. Diaz AM, Abeger A. Study of the polyphenolic compounds present in alcoholic extracts of Myrtus communis L. seeds. Ann Real Acad Farm 1986; 52: 541-546.
22. Guarrera PM. Il patrimonio etnobotanico del Lazio Roma: Tipar. Regione Lazio, Assessorato alla Cultura e Dipartimento di Biologia Vegetale Universita "La Sapienza", 1994, pp. 189-199.
23. Romani A, Pinelli P, Mulinacci N, Vincieri FF, Tattini M. Identification and quantification of polyphenols in leaves of Myrtus communis. Chromatographia 1999; 49: 17-20.
24. Yoshimura M, Amakura Y, Tokuhara M, Yoshida T. Polyphenolic compounds isolated from the leaves of Myrtus communis. J Nat Med 2008; 62: 366-368.
25. Aidi WW, Mhamdi B, Marzouk B. Essential oil composition of two Myrtus communis L. varieties grown in North Tunisia. Italian J Biochem 2007; 56: 180-186.
26. Zia-Ul-Haq M, Stankovic MS, Rizwan K, De Feo V. Grewia asiatica L., a food plant with multiple uses. Molecules 2013; 18: 2663-2682.
27. Zia-Ul-Haq M, Ahmad, S, Amarowicz, R, De Feo V. Antioxidant activity of the extracts of some cowpea (Vigna unguiculata (L) Walp.) cultivars commonly consumed in Pakistan. Molecules 2013; 18: 2005-2017.
28. Zia-Ul-Haq M, Landa P, Kutil Z, Ahmad S. Evaluation of anti-inflammatory activity of selected legumes from Pakistan: in vitro inhibition of cyclooxygenase-2. Pak J Pharm Sci 2013; 26: 185-187.
29. Zia-Ul-Haq M, Ahmad S, Qayum M, Ercisli S. Compositional studies and antioxidant potential of Albizia Lebbeck (L.) Benth. Turk J Biol 2013; 37: 25-32.
30. Zia-Ul-Haq M, Cavar S, Qayum M, Khan I, Ahmad S. Compositional studies and antioxidant potential of Acacia leucophloea Roxb. Acta Bot Croat 2013; 72: 133-144.
31. Zia-Ul-Haq M, Cavar S, Qayum M, Imran I, De Feo V. Compositional studies: antioxidant and antidiabetic activities of Capparis decidua (Forsk.) Edgew Int J Mol Sci 2011; 12: 8846-8861.
32. Zia-Ul-Haq M, Riaz M, De Feo V. Ipomea hederacea Jacq.: a medicinal herb with promising health benefits. Molecules 2012; 17: 13132-13145.
33. Tona, L, Kambu, K, Ngimbi N, Vlietinck AJ. Antiamoebic and phytochemical screening of some Congolese medicinal plants. J Ethnopharmacol 1998; 61: 57-65.
34. Gilani AH, Bashir S, Janbaz KH, Khan AU. Pharmacological basis for the use of Fumaria indica in constipation and diarrhea. J Ethnopharmacol 2005; 96: 585-589.
35. Gilani AH, Janbaz KH, Lateef A, Zaman M, Tariq SR, Ahmed HR. Hypotensive and spasmolytic activities of crude extract of Cyprus scariosus. Arch Pharm Res 1994; 17: 145-149.
36. ++antagonists. Gen Pharmacol 1991; 22: 177-181.
37. Van Rossum JM. Cumulative dose-response curves. II. Technique for the making of dose response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Therap 1963; 143: 299-330.
38. Janbaz KH, Latif MF, Saqib F, Imran I, Zia-Ul-Haq M, De Feo V. Pharmacological effects of Lactuca serriola L in experimental model of gastrointestinal, respiratory and vascular ailments. Evid Based Complement Alternat Med 2013; 2013: 1-9.
39. Janbaz KH, Haider S, Imran I, Zia-Ul-Haq M, Martino LD, De Feo V. Pharmacological evaluation of Prosopis cineraria (L.) Druce in gastrointestinal, respiratory, and vascular disorders. Evid Based Complement Alternat Med 2012; 2012: 1-7.
40. Imran I, Hussain L, Zia-Ul-Haq M, Janbaz KH, Gilani AH, De Feo V. Gastrointestial and respiratory activities of Acacia leucophloea. J Ethnopharmacol 2011; 138: 676-679.
41. Gilani AH, Bashir S, Janbaz KH, Jabar A. Presence of cholinergic and calcium channel blocking activities explains the traditional use of Hibiscus rosasinensis in constipation and diarrhea. J Ethnopharmacol 2005; 102: 289-294.
42. Kanner J, Lapidot T. The stomach as a bioreactor: dietary lipid peroxidation in the gastric fluid and the effects of plantderived antioxidants. Free Rad Bio Med 2001; 31: 1388-1395.
43. 2+in the contractility of rabbit small intestine in vitro. J Physiol Pharmacol 2004; 55: 639-650.
44. Matsunami M, Kirishi S, Okui T, Kawabata A. Hydrogen sulfide-induced colonic mucosal cytoprotection involves Ttype calcium channel-dependent neuronal excitation in rats. J Physiol Pharmacol 2012; 63: 61-68.
45. Brading AF. tonic distribution and mechanism of transmembrane ion movements in smooth muscle. In: Smooth Muscle. E. Bulbring, AF Brding, AW. Jones (eds.). London, Edward Arnold Press 1981, pp. 65-92.
46. Bolton TB. Mechanism of action of transmitters and other substances on smooth muscles. Physiolog Rev 1979; 59: 222-226.
47. Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharm Rev 1986; 38: 321-416.
48. Fleckenstein A. Specific Pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol Toxicol 1977; 17: 149-166.
49. Triggle DJ. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Cleveland Clinic J Med 1992; 59: 617-627.
50. Mathewson HS. Anti-asthmatic properties of calcium channel antagonists. Resp Care 1985; 30: 779-781.
51. Kraft M. Approach to the patient with respiratory diseases. In: Cecil Medicine, L. Goldman, D. Ausiello, (eds.) Philadelphia, Saunders Elsevier, 2007, chap 83.
52. Kitic D, Brankovic S, Radenkovic M, et al. Hypotensive, vasorelaxant and cardiodepressant activities of the ethanol extract of Sideritis Raeseri spp. Raeseri Boiss & Heldr. J Physiol Pharmacol 2012; 63: 531-535.